Classical antibody boosting effects during vaccination are accompanied by natural broadening mechanisms that help enable human antibodies to engage conserved sites of vulnerability on influenza virus.

A French study in Cell Reports suggests vaccines could one day be delivered through a simple skin massage — no needles ...

Supported by the Center for Infectious Disease Research and Policy's (CIDRAP) Vaccine Integrity Project (VIP), the ...

Everyone knows that the fall brings flu season, replete with aches, pains and a new version of the vaccine. But why is cold ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

A Human Immune Health Atlas, mapping 71 different immune cells and their changes over time, was released to support studies into the aging immune system.

Trained immunity is reshaping our understanding of host defense by demonstrating that innate immune cells once thought to lack memory can be reprogrammed to mount heightened responses to subsequent ...

Cidara’s CD388 is a novel flu prophylactic designed for universal prevention of seasonal and pandemic influenza through a single dose, with the potential to be the new standard of care. Phase 2 data ...

Redefining National Security Through the Lens of Health A nation’s strength lies not only in its military capabilities or ...

diSArm clinical trial is that our phages injected intravenously can home in to the site of infection, penetrate biofilms, infect, and lyse S. aureus. Many deaths post flu, and most likely also ...

Experts describe their hopes for the independent Australian Centre for Disease Control that will be established officially on ...

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. (OTCQX: VXRT), a clinical-stage ...